首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Validity of Earlier Positivity of Central Venous Blood Cultures in Comparison with Peripheral Blood Cultures for Diagnosing Catheter-Related Bacteremia in Cancer Patients
【2h】

Validity of Earlier Positivity of Central Venous Blood Cultures in Comparison with Peripheral Blood Cultures for Diagnosing Catheter-Related Bacteremia in Cancer Patients

机译:与外周血培养相比中央静脉血培养早期阳性对诊断癌症患者导管相关细菌血症的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We carried out a prospective study in two French Comprehensive Cancer Centers (95 and 184 beds, respectively) to assess the validity of a test based on the earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for predicting catheter-related bacteremia. The differences between the times to positivity for the 21 patients with clinical catheter-related bacteremia and the differences between the times to positivity for the nine patients with bacteremia due to another source were compared by the median test. The difference between the median values was significant (P = 0.0003). A receiver operating characteristic curve was constructed to determine the optimum threshold of the test, which appeared to be at the cutoff point of ≥+3 h, with 100% specificity and 81% sensitivity. The positive and negative predictive values obtained with this cutoff point confirmed the efficacy of the test for predicting the presence or absence of catheter-related bacteremia in cancer patients. The cutoff point was then used to post-classify the 68 episodes of bacteremia from an unknown source. The characteristics and clinical course of both the positive and negative post-classified episodes did not show that the test was clearly useful for a large number of clinical presentations. We therefore suggest restricting it to febrile neutropenic cancer patients for whom clinical signs of infection are slight or absent and when the test is positive.
机译:我们在两个法国综合癌症中心(分别为95张和184张病床)中进行了一项前瞻性研究,以评估中心静脉血培养物与外周血培养物对导管相关菌血症的预测的早期阳性结果为基础,评估测试的有效性。通过中位数测试比较了21例临床导管相关菌血症患者的阳性时间之间的差异和9例由于另一来源而引起的9例细菌血症患者的阳性时间之间的差异。中位数之间的差异是显着的(P = 0.0003)。构建接收器工作特性曲线以确定最佳测试阈值,该阈值似乎在≥+ 3 h的临界点,具有100%的特异性和81%的灵敏度。通过该临界点获得的阳性和阴性预测值证实了该测试方法可预测癌症患者中导管相关菌血症的存在或不存在。然后使用临界点对未知来源的68种细菌血症发作进行后分类。分类后阳性和阴性后发作的特征和临床过程均未显示该测试显然可用于大量临床表现。因此,我们建议将其限制于发热的中性粒细胞减少癌患者,这些患者的临床感染迹象轻微或不存在,并且检测结果呈阳性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号